How the COVID Subvariant XBB.1.5 Got Called ‘the Kraken' — and Is That Fearmongering?

Ireland News News

How the COVID Subvariant XBB.1.5 Got Called ‘the Kraken' — and Is That Fearmongering?
Ireland Latest News,Ireland Headlines
  • 📰 NECN
  • ⏱ Reading Time:
  • 32 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 71%

The new, more contagious COVID subvariant XBB.1.5 that's believed to be New England's most dominant strain of the virus has acquired a dramatic nickname: 'the Kraken.'

XBB.1.5 accounts for a whopping 71% of all COVID-19 casesIn an effort to keep flu and COVID cases down, some school districts have asked students to mask up after returning from holiday break. The move is temporary and is only a suggestion, not a requirement.

"The variant numbers in the CDC tracker are models. They are estimates and they aren't always right. And they may be subject to bias, especially during holiday times," Doron said.Tufts Medical Center's Dr. Shira Doronover the last several weeks, Boston doctors aren't going so far as to call this a surge. And they aren't sounding the alarm over the latest subvariant.

In a tweet earlier this week, Gregory stressed the nickname was"informal." Previous variants have also been given nicknames like the"nightmare" or"scrabble" variants as the virus continually mutates.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NECN /  🏆 20. in UK

Ireland Latest News, Ireland Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Lancashire's Covid hotspot as 'Kraken' variant begins to spreadLancashire's Covid hotspot as 'Kraken' variant begins to spreadLancashire's Covid hotspot as 'ultra-transmissible' Kraken variant begins to spread across UK
Read more »

Profound immune escape by SARS-CoV-2 XBB.1 even after 4 vaccine dosesProfound immune escape by SARS-CoV-2 XBB.1 even after 4 vaccine dosesIn a recent correspondence published in The Lancet Infectious Diseases journal, researchers in Germany assessed the neutralization sensitivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) XBB.1 lineage.
Read more »

Frontiers | Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19Frontiers | Challenges in the Management of SARS-CoV2 Infection: The Role of Oral Bacteriotherapy as Complementary Therapeutic Strategy to Avoid the Progression of COVID-19Background: Gastrointestinal disorders are frequent in COVID-19 and SARS-CoV-2 has been hypothesized to impact on host microbial flora and gut inflammation, infecting intestinal epithelial cells. Since there are currently no coded therapies or guidelines for treatment of COVID-19, this study aimed to evaluate the possible role of a specific oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19. Methods: We provide a report of 70 patients positive for COVID-19, hospitalized between March 9th and April 4th, 2020. All the patients had fever, required non-invasive oxygen therapy and presented a CT lung involvement on imaging more than 50%. Forty-two patients received hydroxychloroquine, antibiotics, and tocilizumab, alone or in combination. A second group of 28 subjects received the same therapy added with oral bacteriotherapy, using a specialized formulation of eight bacterial strains. Results: The two cohorts of patients were comparable for age, sex, laboratory values, concomitant pathologies, and the modality of oxygen support. Within seventy-two hours, nearly all patients treated with bacteriotherapy showed remission of diarrhea and other symptoms as compared to less than half of the not supplemented group. The estimated risk of developing respiratory failure was eight-fold lower in patients receiving oral bacteriotherapy. Both the prevalence of patients transferred to ICU and mortality were higher among the patients not treated with oral bacteriotherapy. Conclusions: A specific bacterial formulation showed a significant ameliorating impact on the clinical conditions of patients positive for SARS-CoV-2 infection. These results also stress the importance of the gut-lung axis in controlling the COVID-19 disease.
Read more »

Australian Open will allow players to compete even if they have Covid-19Australian Open will allow players to compete even if they have Covid-19The Australian Open will allow players to compete even if they have Covid-19. It is a stark contrast to rules players had to follow in 2021 and 2022. Back in 2021, the tournament took place in a bi…
Read more »

China declares 'new phase' in COVID response after Beijing reopens bordersChina declares 'new phase' in COVID response after Beijing reopens bordersAlthough the move to drop quarantine is expected to boost outbound travel, several countries are demanding negative tests from visitors from China. Among the countries seeing Chinese visitors for the first time in years is Thailand.
Read more »



Render Time: 2025-03-06 06:51:16